(Q30437993)

English

Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

21 June 2017

Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer (English)

1 reference

stated in

Europe PubMed Central

21 June 2017

non-small-cell lung carcinoma

1 reference

3

David R Jones

1 reference

stated in

Europe PubMed Central

21 June 2017

Brian K Rundall

1

1 reference

stated in

Europe PubMed Central

PubMed ID

16153448

retrieved

21 June 2017

Chadrick E Denlinger

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

16153448

retrieved

21 June 2017

language of work or name

1 reference

1 August 2005

1 reference

stated in

Europe PubMed Central

21 June 2017

1 reference

Europe PubMed Central

21 June 2017

138

1 reference

stated in

Europe PubMed Central

21 June 2017

2

1 reference

stated in

Europe PubMed Central

21 June 2017

360-367

1 reference

stated in

Europe PubMed Central

PubMed ID

16153448

retrieved

21 June 2017

Identifiers

DOI

10.1016/J.SURG.2005.06.016

1 reference

stated in

Europe PubMed Central

21 June 2017

1 reference

Europe PubMed Central

PubMed ID

16153448

retrieved

21 June 2017

(Q30437993)

Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)